Posterior uveitis
MONDO:0006918Inflammation of the choroid as well as the retina and vitreous body. Some form of visual disturbance is usually present. The most important characteristics of posterior uveitis are vitreous opacities, choroiditis, and chorioretinitis.
Also known as: chorioretinal region inflammation, inflammation of chorioretinal region
23 clinical trials for this condition and its sub-types, 10 tagged with Posterior uveitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Posterior uveitis
-
Retinitis 1 trial · 10 incl. sub-types
5 sub-types
- Optic papillitis 5 trials Sub-types →
- Cytomegalovirus retinitis 2 trials
- Retinal vasculitis 2 trials
- Histoplasmosis retinitis 1 trial
- Acute retinal necrosis syndrome 0 trials
-
Birdshot chorioretinopathy 2 trials
-
Choroiditis 0 trials · 1 incl. sub-types
4 sub-types
- Serpiginous choroiditis 1 trial
- Infectious posterior uveitis 0 trials
- Multifocal choroiditis 0 trials Sub-types →
- Paraneoplastic uveitis 0 trials
Most studied deeper sub-types
-
New drug aims to tame eye inflammation in uveitis patients
Disease control Recruiting nowThis study tests a new drug, GenSci048, in people with active non-infectious uveitis, an inflammatory eye disease. The trial will compare two doses of GenSci048 against a placebo to see if it can control the disease and reduce treatment failure. About 111 adults with active uveit…
Phase 2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for uveitis: Anti-Inflammatory drug tested in chinese patients
Disease control Recruiting nowThis study tests the drug adalimumab (Tebiovio®) in 30 adults with non-infectious uveitis, an inflammatory eye disease. The goal is to see if the drug can control inflammation and prevent treatment failure. Participants will receive injections and be monitored for up to 24 weeks.…
Phase 4 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill could tame eye inflammation without needles
Disease control Recruiting nowThis study tests an oral medication called FXS5626 in 40 adults with active non-infectious uveitis, a condition causing inflammation inside the eye. The goal is to see if the drug can control the disease better than a placebo, reducing the need for other treatments. Participants …
Phase 2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Researchers launch major study to unravel rare eye disease
Knowledge-focused Recruiting nowThis study follows 600 people with birdshot chorioretinopathy, a rare inflammatory eye disease, to better understand its features and causes. Researchers will use imaging, vision tests, and quality-of-life surveys to track the disease over time. They will also analyze DNA to find…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC